,,iv  #aaf? ,,congress  #a/ ,session    
,h4 ,,res4 #aff  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,febru>y #bh1         
#bjai,mr4 ,morelle submitt$ ! foll[+    
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,ov]sight & ,re=m  ,,resolution     
,express+ support = designation ( ,m>*  
#c1 #bjai1 z ,national ,triple-,negative
 ,brea/ ,canc] ,day4  ,:]eas            
triple-negative brea/ canc] 0 recogniz$ 
z a di/9ct type ( canc] 9 #bjjf2 ,:]eas 
triple-negative brea/ canc]             
disproportionately affects "y wom51     
,black & ,hispanic wom51 & ^? ) ,,brca  
g5e mutations2 ,:]eas triple-negative   
brea/ canc]s are e/rog5                 
receptor-negative1 proge/]one           
receptor-negative1 & ,,h]#b-negative1   
mak+ !m di/9ct f o!r brea/ canc]s2      
,:]eas !re is no t>get$ !rapy =         
triple-negative brea/ canc]s2 ,:]eas #aj
 to #bj p]c5t ( all brea/ canc]         
diagnoses are designat$ z               
triple-negative2 ,:]eas triple-negative 
brea/ canc] c be m aggressive & m likely

 to spread & recur2 ,:]eas              
triple-negative brea/ canc] acc\nts =   
ar\nd #be p]c5t ( all dea?s f brea/     
canc] 9 ! ,unit$ ,/ates2 & ,:]eas ,m>*  
#c1 #bjai1 w\ld be an appropriate date  
to designate z ,national                
,triple-,negative ,brea/ ,canc] ,day3   
,n[1 !re=e1 be x  ,t ! ,h\se (          
,repres5tatives supports ! designation (
 ,national ,triple-,negative ,brea/     
,canc] ,day to create aw>5ess ( !       
deva/at+ effect ( ^! canc]s on ,am]ican 
families & ! ne$ = /rong action to      
eradicate triple-negative brea/ canc]4